|
|
BLTP3B |
bridge-like lipid transfer protein family member 3B |
|
|
|
|
|
BRD10 |
bromodomain containing 10 |
|
|
|
|
|
BTG3 |
BTG anti-proliferation factor 3 |
|
|
|
|
|
C10orf55 |
chromosome 10 putative open reading frame 55 |
|
|
|
|
|
C1orf94 |
chromosome 1 open reading frame 94 |
|
|
|
|
|
C7 |
complement C7 |
- Terminal pathway of complement
- Regulation of Complement cascade
|
|
- Late complement pathway defects, including the following seven diseases: C5 deficiency; C6 deficiency; C7 deficiency; C8 alpha-chain deficiency; C8 beta-chain deficiency; C8 gamma-chain deficiency; C9 deficiency
|
|
|
CAMK1 |
calcium/calmodulin dependent protein kinase I |
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Activation of RAC1 downstream of NMDARs
- Activation of RAC1 downstream of NMDARs
|
|
|
|
|
CAMK2B |
calcium/calmodulin dependent protein kinase II beta |
- CaMK IV-mediated phosphorylation of CREB
- HSF1-dependent transactivation
- Trafficking of AMPA receptors
- Unblocking of NMDA receptors, glutamate binding and activation
- Unblocking of NMDA receptors, glutamate binding and activation
- CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
- Ras activation upon Ca2+ influx through NMDA receptor
- Phase 0 - rapid depolarisation
- Ion homeostasis
- RAF activation
- RAF/MAP kinase cascade
- Signaling by moderate kinase activity BRAF mutants
- Signaling by BRAF and RAF1 fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- Interferon gamma signaling
- Regulation of MECP2 expression and activity
- Ion transport by P-type ATPases
- Assembly and cell surface presentation of NMDA receptors
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Long-term potentiation
- Signaling downstream of RAS mutants
- Signaling by RAF1 mutants
|
- [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile
- Fostamatinib
|
|
|
|
CCDC136 |
coiled-coil domain containing 136 |
|
|
|
|
|
CCNK |
cyclin K |
- Formation of RNA Pol II elongation complex
- Formation of HIV elongation complex in the absence of HIV Tat
- HIV elongation arrest and recovery
- Pausing and recovery of HIV elongation
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- RNA Polymerase II Pre-transcription Events
- TP53 Regulates Transcription of DNA Repair Genes
- RNA polymerase II transcribes snRNA genes
- RNA polymerase II transcribes snRNA genes
- RNA Polymerase II Transcription Elongation
|
|
|
|
|
CDIP1 |
cell death inducing p53 target 1 |
|
|
|
|
|
CDK6 |
cyclin dependent kinase 6 |
- Oxidative Stress Induced Senescence
- Senescence-Associated Secretory Phenotype (SASP)
- Oncogene Induced Senescence
- Cyclin D associated events in G1
- Regulation of RUNX1 Expression and Activity
- Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
- Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
- Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
- Drug-mediated inhibition of CDK4/CDK6 activity
|
- Alvocidib
- (2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol
- Fisetin
- Palbociclib
- Ribociclib
- Abemaciclib
- Trilaciclib
|
|
|
|
CDRT15P3 |
CDRT15 pseudogene 3 |
|
|
|
|
|
CFL1 |
cofilin 1 |
- Platelet degranulation
- Regulation of actin dynamics for phagocytic cup formation
- EPHB-mediated forward signaling
- Sema3A PAK dependent Axon repulsion
- RHO GTPases Activate ROCKs
- Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
|
- Dodecyldimethylamine N-oxide
- Copper
- Artenimol
|
|
|
|
CHRNA7 |
cholinergic receptor nicotinic alpha 7 subunit |
- Highly calcium permeable postsynaptic nicotinic acetylcholine receptors
|
- Choline
- Nicotine
- Succinylcholine
- Butabarbital
- Butalbital
- Talbutal
- Pentobarbital
- Methadone
- Secobarbital
- Metharbital
- Dextromethorphan
- Cisatracurium
- Thiopental
- Mecamylamine
- Galantamine
- Primidone
- Methylphenobarbital
- Ethanol
- Amantadine
- Phenobarbital
- Tubocurarine
- Varenicline
- Amobarbital
- Aprobarbital
- Butobarbital
- Heptabarbital
- Hexobarbital
- Barbital
- Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
- Acetylcholine
- Lobeline
- GTS-21
- RPI-78M
- Epibatidine
- Cytisine
- Cannabidiol
- Encenicline
- Choline salicylate
- Medical Cannabis
- Nabiximols
|
|
|
|
CIC |
capicua transcriptional repressor |
|
|
|
|
|
CIRBP |
cold inducible RNA binding protein |
|
|
|
|
|
CLASRP |
CLK4 associating serine/arginine rich protein |
|
|
|
|
|
CLCN2 |
chloride voltage-gated channel 2 |
|
- Lubiprostone
- Cobiprostone
|
- Idiopathic generalied epilepsies (IGEs), including: Childhood absence epilepsy (CAE); Juvenile absence epilepsy (JAE); Juvenile myoclonic epilepsy (JME); Epilepsy with generalized tonic-clonic seizures alone
|
|
|
CLEC4F |
C-type lectin domain family 4 member F |
|
|
|